Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving hundreds of leading biopharmaceutical companies globally:

Daiichi Sankyo
Dow
Baxter
Deloitte
McKinsey
Boehringer Ingelheim
Express Scripts
Chubb
Johnson and Johnson

Generated: May 27, 2018

DrugPatentWatch Database Preview

Claims for Patent: 3,985,758

« Back to Dashboard

Summary for Patent: 3,985,758
Title: 1,4-Dihydropyridine derivatives
Abstract:There are provided novel 1,4-dihydropyridine derivatives, particularly 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino)ethyl ester and 5-methyl ester. The 1,4-dihydropyridine derivatives are characterized by cerebral vascular dilator activity.
Inventor(s): Murakami; Masuo (Tokyo, JA), Takahashi; Kozo (Tokyo, JA), Iwanami; Masaru (Yokohama, JA), Fujimoto; Masaharu (Tokyo, JA), Shibanuma; Tadao (Asaka, JA), Kawai; Ryutaro (Shiraoka, JA), Takenaka; Toichi (Tokyo, JA)
Assignee: Yamanouchi Pharmaceutical Co., Ltd. (Tokyo, JA)
Application Number:05/584,268
Patent Litigation and PTAB cases: See patent lawsuits and PTAB cases for patent 3,985,758
Patent Claims: 1. A compound of the formula ##SPC10##

wherein R represents hydrogen or lower alkyl; R.sup.1 and R.sup.2 each represents methyl; R.sup.3 represents phenyl, benzyl, halobenzyl, lower alkoxy-benzyl; R.sup.4 represents hydrogen, methyl or ethyl; A represents lower alkylene; R.sup.5 represents methyl, or lower alkoxy, or lower alkoxy substituted with lower alkoxy, or ##EQU1## in which R.sup.3 and R.sup.4 have the same meaning as above; and R.sup.6 represents nitro or trifluoromethyl.

2. The 1,4-dihydropyridine compound as claimed in claim 1 wherein said R is hydrogen, said R.sup.1 and R.sup.2 each represents methyl; said R.sup.3 represents benzyl; said R.sup.4 represents methyl or ethyl; said R.sup.5 represents lower alkoxy; and said R.sup.6 represents nitro.

3. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino ethyl ester 5-methyl ester.

4. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino) ethyl ester 5-ethyl ester.

5. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino) ethyl ester 5-isopropyl ester.

6. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-ethylamino) ethyl ester 5-isopropyl ester.

7. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-benzyl-N-methylamino) propyl ester 5-isopropyl ester.

8. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-p-methoxybenzyl-N-methylamino) ethyl ester 5-ethyl ester.

9. The 1,4-dihydropyridine compound as claimed in claim 1 which is 2,6-dimethyl-4-(3'-nitrophenyl)-1,4-dihydropyridine-3,5-dicarboxylic acid 3-.beta.-(N-p-chlorobenzyl-N-methylamino) ethyl ester 5-ethyl ester.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

Cipla
Teva
Julphar
Healthtrust
Citi
Fish and Richardson
US Department of Justice
Colorcon
AstraZeneca

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.